Kane Biotech

About:

Kane Biotech is a biotechnology company that engages in the research and development of products to prevent and disperse biofilms.

Website: http://www.kanebiotech.com

Top Investors: U.S. Department of Defense, Government of Canada, National Research Council of Canada Industrial Research Assistance Program, Western Economic Diversification Canada, Manitoba

Description:

Kane Biotech Inc., a biotechnology company, engages in the research and development of products to prevent and disperse biofilms in medical and industrial applications. Its products include ALEDEX, an antimicrobial/antibiofilm composition comprising protamine sulfate and chlorhexidine, with applications in anti-infective medical device coatings, animal care and dairy, and food processing industries; DispersinB, an antibiofilm enzyme that inhibits, as well as disperses microbial biofilms, with applications in wound care, medical devices, oral care, and animal healthcare; and a toothpaste and mouthwash additive based on competence stimulating peptide technology for preventing and dispersing dental plaque biofilms. The company was founded in 2001 and is headquartered in Winnipeg, Canada.

Total Funding Amount:

$27M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Winnipeg, Manitoba, Canada

Founded Date:

2001-01-01

Contact Email:

info(AT)kanebiotech.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2023-08-03

IPO Status:

Public

Industries:

© 2025 bioDAO.ai